Pharma major Lupin today said it has received approval from the UK health regulator for its Goa facility. Lupin in a regulatory filing said, “it has received approval from UK MHRA (United Kingdom’s Medicines and Healthcare Products Regulatory Agency) for its Goa facility.
The unit was inspected by UK MHRA in March 2018 and there were no critical or major observations cited, it added. Shares of Lupin were trading 2.35 per cent lower at Rs 844.90 on BSE.